28 Mar 2013 07:02
Amphion Innovations plc
Change of Adviser
London and New York, 28 March 2013 - Amphion Innovations plc (AIM: AMP), the developer of medical and technology businesses, is pleased to announce the appointment of Panmure Gordon (UK) Limited as its nominated adviser and broker with immediate effect.
Enquiries:
Amphion Innovations +1 212 210 6224
Charlie Morgan
Panmure Gordon (Nominated Adviser and Broker) +44 (0)20 7886 2500
Freddy Crossley / Grishma Patel (Corporate Finance)
Adam Pollock/ Victoria Boxall (Corporate Broking)
Novella Communications
Tim Robertson +44 (0) 7900 927 650
About Amphion
Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. The Amphion model has been refined to optimise the commericialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.
On the web: www.amphionplc.com